ArticleCureus2024
From Psychiatric Care to Dermatologic Dilemmas: A Case Report of Risperidone-Induced Bullous Pemphigoid.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The patient, a 64-year-old male with a history of delusional disorder, first experienced symptoms of suspicion toward his spouse at age 34. He was treated with psychotropic drugs for two years, leading to complete symptom remission and discontinuation of medication. After years of stability, delusions resurfaced two years ago. Amisulpride was ineffective, and risperidone was started but led to itching and plaques on his thighs, which evolved into fluid-filled and hemorrhagic lesions. Diagnosed with bullous pemphigoid (BP) via skin biopsy, he received corticosteroids, dapsone, and antibiotics. Risperidone was discontinued, but delusions reappeared, prompting its reintroduction. New bullous lesions emerged, suggesting risperidone's role in triggering them. Risperidone was replaced with aripiprazole, and melatonin improved sleep. The patient responded well, with both delusional symptoms and skin condition well-managed. This case highlights the need to consider drug-induced BP in elderly patients on antipsychotic medications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.